Dallas Allergy Immunology Research

Dallas, Texas 75230

0 studies enrolling now · 5 studies all time

What they study most

Agammaglobulinemia, Antibody Deficiency, Asthma, Common Variable Immunodeficiency, Hyper-IgM Syndrome, Hypogammaglobulinemia, Primary Immune Deficiency Disorders, Primary Immunodeficiency, Primary Immunodeficiency Diseases (PID), Seasonal Allergic Rhinitis, X-linked Agammaglobulinaemia

Studies at this site

• Phase 2/3 Study of IGSC, 20% in PIDD — Completed
• Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID) — Completed
• Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases — Completed
• A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma — Completed
• A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR) — Completed